| Name | Market Cap | Current Price | P/E Ratio | Revenue Growth 1Y | Net Margin | ROE | FCF Yield | Debt/Equity |
|---|---|---|---|---|---|---|---|---|
| SGHTSight Sciences, Inc. | 348.95M | 6.60 | -6.41 | -1.47% | -60.63% | -71.72% | 0.46 | |
| RXSTRxSight, Inc. | 402.53M | 9.79 | -13.79 | 57.09% | -25.15% | -12.95% | 0.04 |
| Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|---|
| Sales/Revenue | 7.53M | 23.35M | 27.64M | 48.96M | 71.33M | 81.06M | 79.87M |
| Revenue Growth % | - | 2.1% | 0.18% | 0.77% | 0.46% | 0.14% | -0.01% |
| Cost of Goods Sold | 2.34M | 6.54M | 9.21M | 8.61M | 12.36M | 11.88M | 11.58M |
| COGS % of Revenue | 0.31% | 0.28% | 0.33% | 0.18% | 0.17% | 0.15% | 0.15% |
| Gross Profit | 5.19M | 16.8M | 18.43M | 40.35M | 58.97M | 69.17M | 68.28M |
| Gross Margin % | 0.69% | 0.72% | 0.67% | 0.82% | 0.83% | 0.85% | 0.85% |
| Gross Profit Growth % | - | 2.24% | 0.1% | 1.19% | 0.46% | 0.17% | -0.01% |
| Operating Expenses | 19.49M | 40.84M | 50.62M | 91.82M | 142.92M | 126.45M | 118.82M |
| OpEx % of Revenue | 2.59% | 1.75% | 1.83% | 1.88% | 2% | 1.56% | 1.49% |
| Selling, General & Admin | 14.06M | 32.72M | 41.74M | 76.19M | 120.06M | 108.89M | 100.83M |
| SG&A % of Revenue | 1.87% | 1.4% | 1.51% | 1.56% | 1.68% | 1.34% | 1.26% |
| Research & Development | 5.43M | 8.12M | 8.87M | 15.63M | 22.86M | 17.56M | 17.99M |
| R&D % of Revenue | 0.72% | 0.35% | 0.32% | 0.32% | 0.32% | 0.22% | 0.23% |
| Other Operating Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -14.3M | -24.04M | -32.19M | -51.48M | -83.95M | -57.27M | -50.53M |
| Operating Margin % | -1.9% | -1.03% | -1.16% | -1.05% | -1.18% | -0.71% | -0.63% |
| Operating Income Growth % | - | -0.68% | -0.34% | -0.6% | -0.63% | 0.32% | 0.12% |
| EBITDA | -14.23M | -23.61M | -31.63M | -50.28M | -82.7M | -56.66M | -49.82M |
| EBITDA Margin % | -1.89% | -1.01% | -1.14% | -1.03% | -1.16% | -0.7% | -0.62% |
| EBITDA Growth % | - | -0.66% | -0.34% | -0.59% | -0.64% | 0.31% | 0.12% |
| D&A (Non-Cash Add-back) | 63K | 432K | 554K | 1.2M | 1.25M | 614K | 712K |
| EBIT | -14.3M | -23.9M | -32.23M | -58.41M | -81.73M | -50.03M | -46.61M |
| Net Interest Income | 1K | -1.79M | -2.37M | -4.37M | -4.47M | -5.41M | -4.66M |
| Interest Income | 1K | 174K | 30K | 0 | 0 | 0 | 0 |
| Interest Expense | 0 | 1.96M | 2.4M | 4.37M | 4.47M | 5.41M | 4.66M |
| Other Income/Expense | 1K | -1.82M | -2.44M | -11.29M | -2.24M | 1.84M | -739K |
| Pretax Income | -14.3M | -25.86M | -34.63M | -62.77M | -86.19M | -55.44M | -51.27M |
| Pretax Margin % | -1.9% | -1.11% | -1.25% | -1.28% | -1.21% | -0.68% | -0.64% |
| Income Tax | -6K | 8K | 61K | 188K | 47K | 110K | 236K |
| Effective Tax Rate % | 1% | 1% | 1% | 1% | 1% | 1% | 1% |
| Net Income | -14.29M | -25.87M | -34.69M | -62.96M | -86.24M | -55.55M | -51.51M |
| Net Margin % | -1.9% | -1.11% | -1.26% | -1.29% | -1.21% | -0.69% | -0.64% |
| Net Income Growth % | - | -0.81% | -0.34% | -0.81% | -0.37% | 0.36% | 0.07% |
| Net Income (Continuing) | -14.29M | -25.87M | -34.69M | -62.96M | -86.24M | -55.55M | -51.51M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.44 | -0.77 | -0.74 | -1.33 | -1.80 | -1.14 | -1.03 |
| EPS Growth % | - | -0.75% | 0.04% | -0.8% | -0.35% | 0.37% | 0.1% |
| EPS (Basic) | -0.44 | -0.55 | -0.74 | -1.33 | -1.80 | -1.14 | -1.03 |
| Diluted Shares Outstanding | 32.2M | 33.63M | 46.77M | 47.5M | 47.85M | 48.63M | 50.13M |
| Basic Shares Outstanding | 32.2M | 33.63M | 46.77M | 47.5M | 47.85M | 48.63M | 50.13M |
| Dividend Payout Ratio | - | - | - | - | - | - | - |
| Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|---|
| Total Current Assets | 7.16M | 28M | 70.63M | 277.04M | 209.68M | 162.87M | 139.77M |
| Cash & Short-Term Investments | 4.24M | 21.24M | 61.51M | 260.69M | 185M | 138.13M | 120.36M |
| Cash Only | 4.24M | 21.24M | 61.51M | 260.69M | 185M | 138.13M | 120.36M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 1.81M | 4.09M | 5.36M | 8.71M | 15.15M | 14.29M | 10.79M |
| Days Sales Outstanding | 87.98 | 64 | 70.82 | 64.93 | 77.51 | 64.34 | 49.29 |
| Inventory | 486K | 2.24M | 2.6M | 3.48M | 6.11M | 7.85M | 6.33M |
| Days Inventory Outstanding | 75.87 | 125.16 | 102.97 | 147.31 | 180.54 | 241.13 | 199.35 |
| Other Current Assets | 0 | 0 | 0 | 0 | 3.42M | 2.6M | 2.31M |
| Total Non-Current Assets | 930K | 2.74M | 2.17M | 3.15M | 3.4M | 3.78M | 3.06M |
| Property, Plant & Equipment | 868K | 2.57M | 1.79M | 2.95M | 3.19M | 3.1M | 2.52M |
| Fixed Asset Turnover | 8.68x | 9.08x | 15.47x | 16.60x | 22.40x | 26.16x | 31.76x |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 62K | 168K | 386K | 202K | 211K | 682K | 550K |
| Total Assets | 8.09M | 30.74M | 72.81M | 280.19M | 213.07M | 166.65M | 142.84M |
| Asset Turnover | 0.93x | 0.76x | 0.38x | 0.17x | 0.33x | 0.49x | 0.56x |
| Asset Growth % | - | 2.8% | 1.37% | 2.85% | -0.24% | -0.22% | -0.14% |
| Total Current Liabilities | 2.9M | 7.34M | 9.31M | 13.5M | 17.82M | 12.25M | 15.47M |
| Accounts Payable | 1.88M | 2.31M | 2.16M | 3.35M | 2.69M | 1.73M | 1.69M |
| Days Payables Outstanding | 293.34 | 129.12 | 85.53 | 142.06 | 79.37 | 53.18 | 53.3 |
| Short-Term Debt | 0 | 0 | 0 | 0 | 0 | 2.22M | 0 |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 328K | 0 | 4.07M | 5.99M | 7.35M | 4.53M | 9.68M |
| Current Ratio | 2.47x | 3.82x | 7.58x | 20.52x | 11.77x | 13.29x | 9.04x |
| Quick Ratio | 2.31x | 3.51x | 7.30x | 20.26x | 11.43x | 12.65x | 8.63x |
| Cash Conversion Cycle | -129.49 | 60.04 | 88.26 | 70.19 | 178.68 | 252.3 | 195.34 |
| Total Non-Current Liabilities | 34.16M | 78.09M | 152.34M | 34.58M | 35.18M | 34.18M | 39.85M |
| Long-Term Debt | 34.15M | 12.86M | 31.95M | 32.66M | 33.31M | 31.71M | 39.36M |
| Capital Lease Obligations | 0 | 528K | 134K | 1.04M | 635K | 914K | 473K |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 7K | 64.7M | 120.25M | 879K | 1.23M | 1.56M | 19K |
| Total Liabilities | 37.06M | 85.42M | 161.66M | 48.08M | 53M | 46.44M | 55.32M |
| Total Debt | 34.15M | 13.94M | 32.48M | 34.21M | 34.98M | 35.41M | 40.36M |
| Net Debt | 29.91M | -7.3M | -29.03M | -226.48M | -150.02M | -102.72M | -80M |
| Debt / Equity | - | - | - | 0.15x | 0.22x | 0.29x | 0.46x |
| Debt / EBITDA | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - |
| Interest Coverage | - | -12.26x | -13.39x | -11.79x | -18.80x | -10.59x | -10.84x |
| Total Equity | -28.96M | -54.68M | -88.85M | 232.11M | 160.08M | 120.22M | 87.52M |
| Equity Growth % | - | -0.89% | -0.62% | 3.61% | -0.31% | -0.25% | -0.27% |
| Book Value per Share | -0.90 | -1.63 | -1.90 | 4.89 | 3.35 | 2.47 | 1.75 |
| Total Shareholders' Equity | -28.96M | -54.68M | -88.85M | 232.11M | 160.08M | 120.22M | 87.52M |
| Common Stock | 9K | 9K | 9K | 48K | 48K | 49K | 51K |
| Retained Earnings | -29.48M | -55.35M | -90.04M | -153M | -239.24M | -294.79M | -346.3M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | -34.15M | -64.49M | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|---|
| Cash from Operations | -14.47M | -25M | -32.17M | -52.54M | -75.97M | -47.18M | -22.35M |
| Operating CF Margin % | -1.92% | -1.07% | -1.16% | -1.07% | -1.06% | -0.58% | -0.28% |
| Operating CF Growth % | - | -0.73% | -0.29% | -0.63% | -0.45% | 0.38% | 0.53% |
| Net Income | -14.29M | -25.87M | -34.69M | -62.96M | -86.24M | -55.55M | -51.51M |
| Depreciation & Amortization | 63K | 295K | 554K | 632K | 710K | 614K | 712K |
| Stock-Based Compensation | 52K | 118K | 497K | 5.08M | 12.96M | 14.58M | 17.08M |
| Deferred Taxes | 0 | 0 | 0 | 7.76M | 0 | 0 | 0 |
| Other Non-Cash Items | 58K | 800K | 684K | 1.27M | 2.3M | 2.3M | 2.37M |
| Working Capital Changes | -358K | -341K | 784K | -4.33M | -5.7M | -9.13M | 9M |
| Change in Receivables | -1.42M | -2.32M | -1.48M | -3.69M | -6.84M | 661K | 3.54M |
| Change in Inventory | -184K | -1.8M | -1.72M | -1.31M | -3.25M | -2.16M | 1.63M |
| Change in Payables | 1M | 168K | 448K | 1.17M | -694K | -883K | 336K |
| Cash from Investing | -570K | -672K | -953K | -813K | -970K | -791K | -385K |
| Capital Expenditures | -570K | -672K | -953K | -813K | -970K | -791K | -385K |
| CapEx % of Revenue | 0.08% | 0.03% | 0.03% | 0.02% | 0.01% | 0.01% | 0% |
| Acquisitions | - | - | - | - | - | - | - |
| Investments | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing | 12.2M | 42.66M | 73.4M | 252.53M | 1.25M | 1.1M | 4.96M |
| Debt Issued (Net) | - | - | - | - | - | - | - |
| Equity Issued (Net) | - | - | - | - | - | - | - |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | - | - | - | - | - | - | - |
| Other Financing | -23K | -2.09M | -154K | -4.15M | 0 | -224K | -261K |
| Net Change in Cash | - | - | - | - | - | - | - |
| Free Cash Flow | -15.04M | -25.67M | -33.13M | -53.35M | -76.94M | -47.98M | -22.74M |
| FCF Margin % | -2% | -1.1% | -1.2% | -1.09% | -1.08% | -0.59% | -0.28% |
| FCF Growth % | - | -0.71% | -0.29% | -0.61% | -0.44% | 0.38% | 0.53% |
| FCF per Share | -0.47 | -0.76 | -0.71 | -1.12 | -1.61 | -0.99 | -0.45 |
| FCF Conversion (FCF/Net Income) | 1.01x | 0.97x | 0.93x | 0.83x | 0.88x | 0.85x | 0.43x |
| Interest Paid | 0 | 1.15M | 1.29M | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Metric | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | - | - | - | -87.9% | -43.98% | -39.64% | -49.59% |
| Return on Invested Capital (ROIC) | -1129.9% | - | - | -686.25% | -802.98% | -311.76% | -302.85% |
| Gross Margin | 68.95% | 71.97% | 66.68% | 82.41% | 82.67% | 85.34% | 85.5% |
| Net Margin | -189.77% | -110.8% | -125.52% | -128.61% | -120.9% | -68.53% | -64.49% |
| Debt / Equity | - | - | - | 0.15x | 0.22x | 0.29x | 0.46x |
| Interest Coverage | - | -12.26x | -13.39x | -11.79x | -18.80x | -10.59x | -10.84x |
| FCF Conversion | 1.01x | 0.97x | 0.93x | 0.83x | 0.88x | 0.85x | 0.43x |
| Revenue Growth | - | 210.07% | 18.38% | 77.12% | 45.7% | 13.63% | -1.47% |
| 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|
| Surgical Glaucoma | 46.5M | 65.59M | 74.31M | 75.9M |
| Surgical Glaucoma Growth | - | 41.07% | 13.29% | 2.14% |
| Dry Eye | 2.46M | 5.74M | 6.75M | 3.96M |
| Dry Eye Growth | - | 133.21% | 17.59% | -41.24% |
Sight Sciences, Inc. (SGHT) reported $76.1M in revenue for fiscal year 2024. This represents a 910% increase from $7.5M in 2018.
Sight Sciences, Inc. (SGHT) saw revenue decline by 1.5% over the past year.
Sight Sciences, Inc. (SGHT) reported a net loss of $46.1M for fiscal year 2024.
Sight Sciences, Inc. (SGHT) has a return on equity (ROE) of -49.6%. Negative ROE indicates the company is unprofitable.
Sight Sciences, Inc. (SGHT) had negative free cash flow of $31.8M in fiscal year 2024, likely due to heavy capital investments.